Shopping Cart 0
Cart Subtotal
AED 0

IsoRay Inc (ISR) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

IsoRay Inc (IsoRay), formerly Century Park Pictures Corporation, is a medical technology company which develops, manufactures and markets isotope-based personalized brachytherapy products and devices for the treatment of cancer and other malignant tumors. The company produced Cesium-131, a radioactive isotope used in brachytherapy for the treatment of prostate, brain, lung, head, neck and gynecological cancers. Brachytherapy involves placing the radiation sources-seeds-very close to the tumor site in order to destroy the cancer cells. Cesium 131 provides a specifically targeted, quick-acting radiation treatment. Its initial application is the treatment of localized prostate cancer. It serves medical centers, hospitals and clinics across the US. IsoRay is headquartered in Richland, Washington, the US.

IsoRay Inc (ISR)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

IsoRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

IsoRay Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

IsoRay Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

IsoRay Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

IsoRay Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

IsoRay Inc, Medical Equipment, Deal Details 11

Equity Offering 11

IsoRay to Raise USD8.3 Million in Private Placement of Shares 11

IsoRay Completes Private Placement Of Shares For USD 14.7 Million 13

IsoRay Amends Terms Of Public Offering Of Units For USD 3.7 Million 14

IsoRay Inc-Key Competitors 15

IsoRay Inc-Key Employees 16

IsoRay Inc-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Recent Developments 18

Financial Announcements 18

May 03, 2018: IsoRay Announces Third Quarter Fiscal 2018 Revenue of USD 1.57 Million, 23% Third Quarter-Over-Third Quarter Increase 18

Apr 18, 2018: IsoRay Announces Preliminary Third Quarter Fiscal 2018 Financial Results 19

Jan 24, 2018: IsoRay Announces Preliminary Second Quarter F2018 Revenue of USD 1.54 Million, 50% Year-over-Year Increase 20

Nov 14, 2017: IsoRay Announces First Quarter Fiscal 2018 Financial Results 21

Aug 04, 2017: IsoRay Announces Preliminary Fourth Quarter F2017 Revenue of USD 1.37 Million, 22% Year-over-Year Increase 22

May 10, 2017: IsoRay Announces Third Quarter Fiscal 2017 Financial Results 23

Feb 08, 2017: IsoRay Announces Second Quarter Fiscal 2017 Financial Results 25

Corporate Communications 27

Jun 19, 2018: IsoRay Announces Entry into Employment Agreement with Lori A. Woods as Interim CEO 27

Jun 05, 2018: IsoRay Announces Senior Management Change 28

Jul 07, 2017: Isoray announces appointment of mark austin as controller, principal accounting and financial officer 29

Legal and Regulatory 30

Mar 09, 2017: IsoRay Announces Final Court Approval of Class Action Settlement 30

Government and Public Interest 31

Sep 12, 2018: IsoRay: Three recent peer-reviewed publications reinforce the value of brachytherapy as a treatment for prostate cancer 31

Product News 32

Mar 21, 2018: New study reports that combination treatment with brachytherapy yields significantly better outcomes for men with aggressive prostate cancer 32

Sep 26, 2017: IsoRay Announces Study Accepted for Publication in the International Journal of Radiation Oncology, Biology, Physics entitled "Re-irradiation using Permanent Interstitial Brachytherapy 33

Sep 25, 2017: IsoRay Announces "Long-term PSA Outcomes in a Single Institution, Prospective Randomized Cesium-131 / Iodine-125 Permanent Prostate Brachytherapy Trial" Poster Presentation at 2017 Annual American Society for Radiation Oncology Conference 34

May 03, 2017: IsoRay Announces Study Accepted for Publication in The International Journal of Radiation Oncology, Biology, Physics entitled Long-term Quality of Life in Prostate Cancer Patients Treated with Cesium-131 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

IsoRay Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

IsoRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

IsoRay Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

IsoRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

IsoRay Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

IsoRay Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

IsoRay Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

IsoRay Inc, Medical Equipment, Key Facts, 2017 2

IsoRay Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

IsoRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

IsoRay Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

IsoRay Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

IsoRay Inc, Deals By Market, 2012 to YTD 2018 9

IsoRay Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

IsoRay to Raise USD8.3 Million in Private Placement of Shares 11

IsoRay Completes Private Placement Of Shares For USD 14.7 Million 13

IsoRay Amends Terms Of Public Offering Of Units For USD 3.7 Million 14

IsoRay Inc, Key Competitors 15

IsoRay Inc, Key Employees 16

IsoRay Inc, Subsidiaries 17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

IsoRay Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

IsoRay Inc (IsoRay), formerly Century Park Pictures Corporation, is a medical technology company which develops, manufactures and markets isotope-based personalized brachytherapy products and devices for the treatment of cancer and other malignant tumors. The company produced Cesium-131, a radioactive isotope used in brachytherapy for the treatment of prostate, brain, lung, head, neck and gynecological cancers. Brachytherapy involves placing the radiation sources-seeds-very close to the tumor site in order to destroy the cancer cells. Cesium 131 provides a specifically targeted, quick-acting radiation treatment. Its initial application is the treatment of localized prostate cancer. It serves medical centers, hospitals and clinics across the US. IsoRay is headquartered in Richland, Washington, the US.

IsoRay Inc (ISR)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

IsoRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

IsoRay Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

IsoRay Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

IsoRay Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

IsoRay Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

IsoRay Inc, Medical Equipment, Deal Details 11

Equity Offering 11

IsoRay to Raise USD8.3 Million in Private Placement of Shares 11

IsoRay Completes Private Placement Of Shares For USD 14.7 Million 13

IsoRay Amends Terms Of Public Offering Of Units For USD 3.7 Million 14

IsoRay Inc-Key Competitors 15

IsoRay Inc-Key Employees 16

IsoRay Inc-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Recent Developments 18

Financial Announcements 18

May 03, 2018: IsoRay Announces Third Quarter Fiscal 2018 Revenue of USD 1.57 Million, 23% Third Quarter-Over-Third Quarter Increase 18

Apr 18, 2018: IsoRay Announces Preliminary Third Quarter Fiscal 2018 Financial Results 19

Jan 24, 2018: IsoRay Announces Preliminary Second Quarter F2018 Revenue of USD 1.54 Million, 50% Year-over-Year Increase 20

Nov 14, 2017: IsoRay Announces First Quarter Fiscal 2018 Financial Results 21

Aug 04, 2017: IsoRay Announces Preliminary Fourth Quarter F2017 Revenue of USD 1.37 Million, 22% Year-over-Year Increase 22

May 10, 2017: IsoRay Announces Third Quarter Fiscal 2017 Financial Results 23

Feb 08, 2017: IsoRay Announces Second Quarter Fiscal 2017 Financial Results 25

Corporate Communications 27

Jun 19, 2018: IsoRay Announces Entry into Employment Agreement with Lori A. Woods as Interim CEO 27

Jun 05, 2018: IsoRay Announces Senior Management Change 28

Jul 07, 2017: Isoray announces appointment of mark austin as controller, principal accounting and financial officer 29

Legal and Regulatory 30

Mar 09, 2017: IsoRay Announces Final Court Approval of Class Action Settlement 30

Government and Public Interest 31

Sep 12, 2018: IsoRay: Three recent peer-reviewed publications reinforce the value of brachytherapy as a treatment for prostate cancer 31

Product News 32

Mar 21, 2018: New study reports that combination treatment with brachytherapy yields significantly better outcomes for men with aggressive prostate cancer 32

Sep 26, 2017: IsoRay Announces Study Accepted for Publication in the International Journal of Radiation Oncology, Biology, Physics entitled "Re-irradiation using Permanent Interstitial Brachytherapy 33

Sep 25, 2017: IsoRay Announces "Long-term PSA Outcomes in a Single Institution, Prospective Randomized Cesium-131 / Iodine-125 Permanent Prostate Brachytherapy Trial" Poster Presentation at 2017 Annual American Society for Radiation Oncology Conference 34

May 03, 2017: IsoRay Announces Study Accepted for Publication in The International Journal of Radiation Oncology, Biology, Physics entitled Long-term Quality of Life in Prostate Cancer Patients Treated with Cesium-131 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

IsoRay Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

IsoRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

IsoRay Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

IsoRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

IsoRay Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

IsoRay Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

IsoRay Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

IsoRay Inc, Medical Equipment, Key Facts, 2017 2

IsoRay Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

IsoRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

IsoRay Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

IsoRay Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

IsoRay Inc, Deals By Market, 2012 to YTD 2018 9

IsoRay Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

IsoRay to Raise USD8.3 Million in Private Placement of Shares 11

IsoRay Completes Private Placement Of Shares For USD 14.7 Million 13

IsoRay Amends Terms Of Public Offering Of Units For USD 3.7 Million 14

IsoRay Inc, Key Competitors 15

IsoRay Inc, Key Employees 16

IsoRay Inc, Subsidiaries 17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

IsoRay Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.